Purchases and Sales Made in Q4 2024 in Gain Therapeutics, Inc. (GANX)
This table provides information about the institutional ownership of Gain Therapeutics, Inc. (GANX) during Q4 2024. The information is specifically focused on institutions that hold shares of Gain Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
91.7KNew |
$141K - $268K
|
91.7K
$228K
|
|
|
Feb 05, 2025
Q4 2024
|
Jones Financial Companies Lllp
|
BUY
|
- |
44.8K+ 83.64% |
$68.9K - $131K
|
98.3K
$245K
|
|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
31.9K+ 21.94% |
$49.1K - $93K
|
177K
$441K
|
|
|
Jan 28, 2025
Q4 2024
|
Benedict Financial Advisors Inc
|
BUY
|
- |
16KNew |
$24.6K - $46.7K
|
16K
$39.8K
|
|
|
Feb 04, 2025
Q4 2024
|
Sprott Inc.
Toronto, A6 |
BUY
|
- |
14KNew |
$21.6K - $40.9K
|
14K
$34.9K
|
|
|
Feb 12, 2025
Q4 2024
|
Citigroup Inc
|
BUY
|
- |
2KNew |
$3.08K - $5.84K
|
2K
$4.98K
|
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 12, 2025
Q4 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-4.55K- 1.67% |
$7.01K - $13.3K
|
267K
$666K
|